Corday Brian David 13D and 13G filings for Virios Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 6:01 pm Sale | 2024-02-13 | 13G | Virios Therapeutics, Inc. VIRI | Corday Brian David | 882,400 4.600% | -433,649 (-32.95%) | Filing |
| 2023-11-14 1:40 pm Sale | 2023-11-14 | 13G | Virios Therapeutics, Inc. VIRI | Corday Brian David | 1,316,049 6.840% | -11,002 (-0.83%) | Filing |
| 2023-06-13 4:41 pm Purchase | 2023-06-13 | 13G | Virios Therapeutics, Inc. VIRI | Corday Brian David | 1,327,051 7.300% | 27,071 (+2.08%) | Filing |
| 2023-05-15 1:37 pm Purchase | 2023-05-15 | 13G | Virios Therapeutics, Inc. VIRI | Corday Brian David | 1,299,980 7.100% | 36,782 (+2.91%) | Filing |
| 2023-03-31 2:33 pm Purchase | 2023-03-30 | 13G | Virios Therapeutics, Inc. VIRI | Corday Brian David | 1,263,198 6.900% | 113,449 (+9.87%) | Filing |
| 2023-02-13 2:48 pm Purchase | 2023-02-13 | 13G | Virios Therapeutics, Inc. VIRI | Corday Brian David | 1,149,749 6.300% | 76,797 (+7.16%) | Filing |
| 2022-12-21 1:43 pm Purchase | 2022-12-14 | 13G | Virios Therapeutics, Inc. VIRI | Corday Brian David | 1,072,952 5.900% | 1,072,952 (New Position) | Filing |